APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Computer-Aided Drug

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Computer-Aided Drug Market Outlook and Growth Opportunities 2026

Report ID 173980540431 December 2025198 pages

Choose your research edition.

Industry ResearchComputer-Aided Drug Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Computer-Aided Drug Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Computer-Aided Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Computer-Aided Drug Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Computer-Aided Drug Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Computer-Aided Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Computer-Aided Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Computer-Aided Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Computer-Aided Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Computer-Aided Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Computer-Aided Drug market include Aaranya Biosciences Pvt. Ltd., Albany Molecular Research Inc., Charles River Laboratories International Inc., Chembio Discovery Inc., Chemical Computing Group ULC, Compchem Solutions Ltd., International Business Machines Corp., Kang Yusheng Information Technology Co. Ltd. and Market Positioning Of Vendors, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Computer-Aided Drug market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Computer-Aided Drug and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Computer-Aided Drug revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Computer-Aided Drug market.

Computer-Aided Drug Segment by Company

Aaranya Biosciences Pvt. Ltd.

Albany Molecular Research Inc.

Charles River Laboratories International Inc.

Chembio Discovery Inc.

Chemical Computing Group ULC

Compchem Solutions Ltd.

International Business Machines Corp.

Kang Yusheng Information Technology Co. Ltd.

Market Positioning Of Vendors

Openeye Scientific Software Inc.

Pharmaron Beijing Co. Ltd.

Computer-Aided Drug Segment by Type

Structure Based Drug

Ligand Based Drug

Computer-Aided Drug Segment by Application

Oncological Disorders

Neurological Disorders

Other

Computer-Aided Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Computer-Aided Drug status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Computer-Aided Drug key companies, revenue, market share, and recent developments.

3. To split the Computer-Aided Drug breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Computer-Aided Drug market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Computer-Aided Drug significant trends, drivers, influence factors in global and regions.

6. To analyze Computer-Aided Drug competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Computer-Aided Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Computer-Aided Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Computer-Aided Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Computer-Aided Drug industry.

Chapter 3: Detailed analysis of Computer-Aided Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Computer-Aided Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Computer-Aided Drug in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Computer-Aided Drug Industry Trends Table 2. Computer-Aided Drug Industry Drivers Table 3. Computer-Aided Drug Industry Opportunities and Challenges Table 4. Computer-Aided Drug Industry Restraints Table 5. Global Computer-Aided Drug Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Computer-Aided Drug Revenue Share by Company (2021-2026) Table 7. Global Computer-Aided Drug Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Computer-Aided Drug Key Company Manufacturing Base & Headquarters Table 9. Global Computer-Aided Drug Company, Product Type & Application Table 10. Global Computer-Aided Drug Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Computer-Aided Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Structure Based Drug Table 15. Significant Companies of Ligand Based Drug Table 16. Global Computer-Aided Drug Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Computer-Aided Drug Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Computer-Aided Drug Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Computer-Aided Drug Sales Value Share by Type (2021-2026) Table 20. Global Computer-Aided Drug Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Oncological Disorders Table 22. Significant Companies of Neurological Disorders Table 23. Significant Companies of Other Table 24. Global Computer-Aided Drug Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Computer-Aided Drug Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Computer-Aided Drug Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Computer-Aided Drug Sales Value Share by Application (2021-2026) Table 28. Global Computer-Aided Drug Sales Value Share by Application (2027-2032) Table 29. Global Computer-Aided Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Computer-Aided Drug Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Computer-Aided Drug Sales Value Share by Region (2021-2026) Table 32. Global Computer-Aided Drug Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Computer-Aided Drug Sales Value Share by Region (2027-2032) Table 34. Global Computer-Aided Drug Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Computer-Aided Drug Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Computer-Aided Drug Sales Value Market Share by Country (2021-2026) Table 37. Global Computer-Aided Drug Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Computer-Aided Drug Sales Value Market Share by Country (2027-2032) Table 39. Aaranya Biosciences Pvt. Ltd. Company Information Table 40. Aaranya Biosciences Pvt. Ltd. Business Overview Table 41. Aaranya Biosciences Pvt. Ltd. Computer-Aided Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Aaranya Biosciences Pvt. Ltd. Computer-Aided Drug Product Portfolio Table 43. Aaranya Biosciences Pvt. Ltd. Recent Development Table 44. Albany Molecular Research Inc. Company Information Table 45. Albany Molecular Research Inc. Business Overview Table 46. Albany Molecular Research Inc. Computer-Aided Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Albany Molecular Research Inc. Computer-Aided Drug Product Portfolio Table 48. Albany Molecular Research Inc. Recent Development Table 49. Charles River Laboratories International Inc. Company Information Table 50. Charles River Laboratories International Inc. Business Overview Table 51. Charles River Laboratories International Inc. Computer-Aided Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Charles River Laboratories International Inc. Computer-Aided Drug Product Portfolio Table 53. Charles River Laboratories International Inc. Recent Development Table 54. Chembio Discovery Inc. Company Information Table 55. Chembio Discovery Inc. Business Overview Table 56. Chembio Discovery Inc. Computer-Aided Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Chembio Discovery Inc. Computer-Aided Drug Product Portfolio Table 58. Chembio Discovery Inc. Recent Development Table 59. Chemical Computing Group ULC Company Information Table 60. Chemical Computing Group ULC Business Overview Table 61. Chemical Computing Group ULC Computer-Aided Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Chemical Computing Group ULC Computer-Aided Drug Product Portfolio Table 63. Chemical Computing Group ULC Recent Development Table 64. Compchem Solutions Ltd. Company Information Table 65. Compchem Solutions Ltd. Business Overview Table 66. Compchem Solutions Ltd. Computer-Aided Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Compchem Solutions Ltd. Computer-Aided Drug Product Portfolio Table 68. Compchem Solutions Ltd. Recent Development Table 69. International Business Machines Corp. Company Information Table 70. International Business Machines Corp. Business Overview Table 71. International Business Machines Corp. Computer-Aided Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. International Business Machines Corp. Computer-Aided Drug Product Portfolio Table 73. International Business Machines Corp. Recent Development Table 74. Kang Yusheng Information Technology Co. Ltd. Company Information Table 75. Kang Yusheng Information Technology Co. Ltd. Business Overview Table 76. Kang Yusheng Information Technology Co. Ltd. Computer-Aided Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Kang Yusheng Information Technology Co. Ltd. Computer-Aided Drug Product Portfolio Table 78. Kang Yusheng Information Technology Co. Ltd. Recent Development Table 79. Market Positioning Of Vendors Company Information Table 80. Market Positioning Of Vendors Business Overview Table 81. Market Positioning Of Vendors Computer-Aided Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Market Positioning Of Vendors Computer-Aided Drug Product Portfolio Table 83. Market Positioning Of Vendors Recent Development Table 84. Openeye Scientific Software Inc. Company Information Table 85. Openeye Scientific Software Inc. Business Overview Table 86. Openeye Scientific Software Inc. Computer-Aided Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Openeye Scientific Software Inc. Computer-Aided Drug Product Portfolio Table 88. Openeye Scientific Software Inc. Recent Development Table 89. Pharmaron Beijing Co. Ltd. Company Information Table 90. Pharmaron Beijing Co. Ltd. Business Overview Table 91. Pharmaron Beijing Co. Ltd. Computer-Aided Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Pharmaron Beijing Co. Ltd. Computer-Aided Drug Product Portfolio Table 93. Pharmaron Beijing Co. Ltd. Recent Development Table 94. Research Programs/Design for This Report Table 95. Authors List of This Report Table 96. Secondary Sources Table 97. Primary Sources List of Figures Figure 1. Computer-Aided Drug Product Image Figure 2. Global Computer-Aided Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Computer-Aided Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Computer-Aided Drug Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Structure Based Drug Image Figure 8. Ligand Based Drug Image Figure 9. Global Computer-Aided Drug Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Computer-Aided Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Computer-Aided Drug Sales Value Share by Type (2021-2032) Figure 12. Oncological Disorders Image Figure 13. Neurological Disorders Image Figure 14. Other Image Figure 15. Global Computer-Aided Drug Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Computer-Aided Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Computer-Aided Drug Sales Value Share by Application (2021-2032) Figure 18. Global Computer-Aided Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Computer-Aided Drug Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Computer-Aided Drug Sales Value (2021-2032) & (US$ Million) Figure 21. North America Computer-Aided Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Computer-Aided Drug Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Computer-Aided Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Computer-Aided Drug Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Computer-Aided Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Computer-Aided Drug Sales Value (2021-2032) & (US$ Million) Figure 27. South America Computer-Aided Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Computer-Aided Drug Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Computer-Aided Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Computer-Aided Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Computer-Aided Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Computer-Aided Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Computer-Aided Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Computer-Aided Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Computer-Aided Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Computer-Aided Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Computer-Aided Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Computer-Aided Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Computer-Aided Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Computer-Aided Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Computer-Aided Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Computer-Aided Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Computer-Aided Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Computer-Aided Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Computer-Aided Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Computer-Aided Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Computer-Aided Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Computer-Aided Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Computer-Aided Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Computer-Aided Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Computer-Aided Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Computer-Aided Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Computer-Aided Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Computer-Aided Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Computer-Aided Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Computer-Aided Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Computer-Aided Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Computer-Aided Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Computer-Aided Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Computer-Aided Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Computer-Aided Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Computer-Aided Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Computer-Aided Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Computer-Aided Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Computer-Aided Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Computer-Aided Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Computer-Aided Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Computer-Aided Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Computer-Aided Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Computer-Aided Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Computer-Aided Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Computer-Aided Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Computer-Aided Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Computer-Aided Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Computer-Aided Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Computer-Aided Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Computer-Aided Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Computer-Aided Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Computer-Aided Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Computer-Aided Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Computer-Aided Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Computer-Aided Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Computer-Aided Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Computer-Aided Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Computer-Aided Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Computer-Aided Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Computer-Aided Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Computer-Aided Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Computer-Aided Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Computer-Aided Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Computer-Aided Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Computer-Aided Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Computer-Aided Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Computer-Aided Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Computer-Aided Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Computer-Aided Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Computer-Aided Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Computer-Aided Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Computer-Aided Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Computer-Aided Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Computer-Aided Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Computer-Aided Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Computer-Aided Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Computer-Aided Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Computer-Aided Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Computer-Aided Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Computer-Aided Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Computer-Aided Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Computer-Aided Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Computer-Aided Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Computer-Aided Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Computer-Aided Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Computer-Aided Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Structure Based Drug
  • Ligand Based Drug
Applications
  • Oncological Disorders
  • Neurological Disorders
  • Other
Companies covered
  • Aaranya Biosciences Pvt. Ltd.
  • Albany Molecular Research Inc.
  • Charles River Laboratories International Inc.
  • Chembio Discovery Inc.
  • Chemical Computing Group ULC
  • Compchem Solutions Ltd.
  • International Business Machines Corp.
  • Kang Yusheng Information Technology Co. Ltd.
  • Market Positioning Of Vendors
  • Openeye Scientific Software Inc.
  • Pharmaron Beijing Co. Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Computer-Aided Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Computer-Aided Drug Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Computer-Aided Drug Market Dynamics
  1. 2.1 Computer-Aided Drug Industry Trends
  2. 2.2 Computer-Aided Drug Industry Drivers
  3. 2.3 Computer-Aided Drug Industry Opportunities and Challenges
  4. 2.4 Computer-Aided Drug Industry Restraints
3 Computer-Aided Drug Market by Company
  1. 3.1 Global Computer-Aided Drug Company Revenue Ranking in 2025
  2. 3.2 Global Computer-Aided Drug Revenue by Company (2021-2026)
  3. 3.3 Global Computer-Aided Drug Company Ranking (2024-2026)
  4. 3.4 Global Computer-Aided Drug Company Manufacturing Base and Headquarters
  5. 3.5 Global Computer-Aided Drug Company Product Type and Application
  6. 3.6 Global Computer-Aided Drug Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Computer-Aided Drug Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Computer-Aided Drug Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Computer-Aided Drug Market by Type
  1. 4.1 Computer-Aided Drug Type Introduction
  2. 4.1.1 Structure Based Drug
  3. 4.1.2 Ligand Based Drug
  4. 4.2 Global Computer-Aided Drug Sales Value by Type
  5. 4.2.1 Global Computer-Aided Drug Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Computer-Aided Drug Sales Value by Type (2021-2032)
  7. 4.2.3 Global Computer-Aided Drug Sales Value Share by Type (2021-2032)
5 Computer-Aided Drug Market by Application
  1. 5.1 Computer-Aided Drug Application Introduction
  2. 5.1.1 Oncological Disorders
  3. 5.1.2 Neurological Disorders
  4. 5.1.3 Other
  5. 5.2 Global Computer-Aided Drug Sales Value by Application
  6. 5.2.1 Global Computer-Aided Drug Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Computer-Aided Drug Sales Value by Application (2021-2032)
  8. 5.2.3 Global Computer-Aided Drug Sales Value Share by Application (2021-2032)
6 Computer-Aided Drug Regional Value Analysis
  1. 6.1 Global Computer-Aided Drug Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Computer-Aided Drug Sales Value by Region (2021-2032)
  3. 6.2.1 Global Computer-Aided Drug Sales Value by Region: 2021-2026
  4. 6.2.2 Global Computer-Aided Drug Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Computer-Aided Drug Sales Value (2021-2032)
  7. 6.3.2 North America Computer-Aided Drug Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Computer-Aided Drug Sales Value (2021-2032)
  10. 6.4.2 Europe Computer-Aided Drug Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Computer-Aided Drug Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Computer-Aided Drug Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Computer-Aided Drug Sales Value (2021-2032)
  16. 6.6.2 South America Computer-Aided Drug Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Computer-Aided Drug Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Computer-Aided Drug Sales Value Share by Country, 2025 VS 2032
7 Computer-Aided Drug Country-level Value Analysis
  1. 7.1 Global Computer-Aided Drug Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Computer-Aided Drug Sales Value by Country (2021-2032)
  3. 7.2.1 Global Computer-Aided Drug Sales Value by Country (2021-2026)
  4. 7.2.2 Global Computer-Aided Drug Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Computer-Aided Drug Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Computer-Aided Drug Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Computer-Aided Drug Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Computer-Aided Drug Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Computer-Aided Drug Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Computer-Aided Drug Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Computer-Aided Drug Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Computer-Aided Drug Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Computer-Aided Drug Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Computer-Aided Drug Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Computer-Aided Drug Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Computer-Aided Drug Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Computer-Aided Drug Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Computer-Aided Drug Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Computer-Aided Drug Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Computer-Aided Drug Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Computer-Aided Drug Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Computer-Aided Drug Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Computer-Aided Drug Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Computer-Aided Drug Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Computer-Aided Drug Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Computer-Aided Drug Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Computer-Aided Drug Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Computer-Aided Drug Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Computer-Aided Drug Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Computer-Aided Drug Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Computer-Aided Drug Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Computer-Aided Drug Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Computer-Aided Drug Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Computer-Aided Drug Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Computer-Aided Drug Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Computer-Aided Drug Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Computer-Aided Drug Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Computer-Aided Drug Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Computer-Aided Drug Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Computer-Aided Drug Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Computer-Aided Drug Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Computer-Aided Drug Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Computer-Aided Drug Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Computer-Aided Drug Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Computer-Aided Drug Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Computer-Aided Drug Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Computer-Aided Drug Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Computer-Aided Drug Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Computer-Aided Drug Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Computer-Aided Drug Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Computer-Aided Drug Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Computer-Aided Drug Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Computer-Aided Drug Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Computer-Aided Drug Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Computer-Aided Drug Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Computer-Aided Drug Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Computer-Aided Drug Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Computer-Aided Drug Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Computer-Aided Drug Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Computer-Aided Drug Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Computer-Aided Drug Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Computer-Aided Drug Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Computer-Aided Drug Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Computer-Aided Drug Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Computer-Aided Drug Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Computer-Aided Drug Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Computer-Aided Drug Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Computer-Aided Drug Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Computer-Aided Drug Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Computer-Aided Drug Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Computer-Aided Drug Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Computer-Aided Drug Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Computer-Aided Drug Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Computer-Aided Drug Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Computer-Aided Drug Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Computer-Aided Drug Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Computer-Aided Drug Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Computer-Aided Drug Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Computer-Aided Drug Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Computer-Aided Drug Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Computer-Aided Drug Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Computer-Aided Drug Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Computer-Aided Drug Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Computer-Aided Drug Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Computer-Aided Drug Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Computer-Aided Drug Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Computer-Aided Drug Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Computer-Aided Drug Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Aaranya Biosciences Pvt. Ltd.
  2. 8.1.1 Aaranya Biosciences Pvt. Ltd. Company Information
  3. 8.1.2 Aaranya Biosciences Pvt. Ltd. Business Overview
  4. 8.1.3 Aaranya Biosciences Pvt. Ltd. Computer-Aided Drug Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Aaranya Biosciences Pvt. Ltd. Computer-Aided Drug Product Portfolio
  6. 8.1.5 Aaranya Biosciences Pvt. Ltd. Recent Developments
  7. 8.2 Albany Molecular Research Inc.
  8. 8.2.1 Albany Molecular Research Inc. Company Information
  9. 8.2.2 Albany Molecular Research Inc. Business Overview
  10. 8.2.3 Albany Molecular Research Inc. Computer-Aided Drug Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Albany Molecular Research Inc. Computer-Aided Drug Product Portfolio
  12. 8.2.5 Albany Molecular Research Inc. Recent Developments
  13. 8.3 Charles River Laboratories International Inc.
  14. 8.3.1 Charles River Laboratories International Inc. Company Information
  15. 8.3.2 Charles River Laboratories International Inc. Business Overview
  16. 8.3.3 Charles River Laboratories International Inc. Computer-Aided Drug Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Charles River Laboratories International Inc. Computer-Aided Drug Product Portfolio
  18. 8.3.5 Charles River Laboratories International Inc. Recent Developments
  19. 8.4 Chembio Discovery Inc.
  20. 8.4.1 Chembio Discovery Inc. Company Information
  21. 8.4.2 Chembio Discovery Inc. Business Overview
  22. 8.4.3 Chembio Discovery Inc. Computer-Aided Drug Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Chembio Discovery Inc. Computer-Aided Drug Product Portfolio
  24. 8.4.5 Chembio Discovery Inc. Recent Developments
  25. 8.5 Chemical Computing Group ULC
  26. 8.5.1 Chemical Computing Group ULC Company Information
  27. 8.5.2 Chemical Computing Group ULC Business Overview
  28. 8.5.3 Chemical Computing Group ULC Computer-Aided Drug Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Chemical Computing Group ULC Computer-Aided Drug Product Portfolio
  30. 8.5.5 Chemical Computing Group ULC Recent Developments
  31. 8.6 Compchem Solutions Ltd.
  32. 8.6.1 Compchem Solutions Ltd. Company Information
  33. 8.6.2 Compchem Solutions Ltd. Business Overview
  34. 8.6.3 Compchem Solutions Ltd. Computer-Aided Drug Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Compchem Solutions Ltd. Computer-Aided Drug Product Portfolio
  36. 8.6.5 Compchem Solutions Ltd. Recent Developments
  37. 8.7 International Business Machines Corp.
  38. 8.7.1 International Business Machines Corp. Company Information
  39. 8.7.2 International Business Machines Corp. Business Overview
  40. 8.7.3 International Business Machines Corp. Computer-Aided Drug Revenue and Gross Margin (2021-2026)
  41. 8.7.4 International Business Machines Corp. Computer-Aided Drug Product Portfolio
  42. 8.7.5 International Business Machines Corp. Recent Developments
  43. 8.8 Kang Yusheng Information Technology Co. Ltd.
  44. 8.8.1 Kang Yusheng Information Technology Co. Ltd. Company Information
  45. 8.8.2 Kang Yusheng Information Technology Co. Ltd. Business Overview
  46. 8.8.3 Kang Yusheng Information Technology Co. Ltd. Computer-Aided Drug Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Kang Yusheng Information Technology Co. Ltd. Computer-Aided Drug Product Portfolio
  48. 8.8.5 Kang Yusheng Information Technology Co. Ltd. Recent Developments
  49. 8.9 Market Positioning Of Vendors
  50. 8.9.1 Market Positioning Of Vendors Company Information
  51. 8.9.2 Market Positioning Of Vendors Business Overview
  52. 8.9.3 Market Positioning Of Vendors Computer-Aided Drug Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Market Positioning Of Vendors Computer-Aided Drug Product Portfolio
  54. 8.9.5 Market Positioning Of Vendors Recent Developments
  55. 8.10 Openeye Scientific Software Inc.
  56. 8.10.1 Openeye Scientific Software Inc. Company Information
  57. 8.10.2 Openeye Scientific Software Inc. Business Overview
  58. 8.10.3 Openeye Scientific Software Inc. Computer-Aided Drug Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Openeye Scientific Software Inc. Computer-Aided Drug Product Portfolio
  60. 8.10.5 Openeye Scientific Software Inc. Recent Developments
  61. 8.11 Pharmaron Beijing Co. Ltd.
  62. 8.11.1 Pharmaron Beijing Co. Ltd. Company Information
  63. 8.11.2 Pharmaron Beijing Co. Ltd. Business Overview
  64. 8.11.3 Pharmaron Beijing Co. Ltd. Computer-Aided Drug Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Pharmaron Beijing Co. Ltd. Computer-Aided Drug Product Portfolio
  66. 8.11.5 Pharmaron Beijing Co. Ltd. Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst